IQVIA (IQV) Q4 Results: Revenue Up 10.3% Amid Margin Pressures and AI Investments

IQVIA (NYSE: IQV) reported Q4 CY2025 results exceeding expectations, with revenue up 10.3% year-on-year to $4.36 billion and non-GAAP profit of $3.42 per share. The midpoint of its full-year revenue guidance of $17.25 billion was 1% above estimates. The market reacted cautiously, citing margin compression and macroeconomic headwinds, despite strong bookings in clinical and commercial services and data-as-a-service. CEO Ari Bousbib attributed growth to AI-driven offerings, integration of acquisitions, and a simplified business structure, while higher interest expenses and pass-through growth pressured margins. Management expects continued focus on AWS and NVIDIA partnerships, expanding commercial outsourcing, and improving productivity to drive long-term efficiency and growth. IQVIA is trading at $181.70, down from $202.54 pre-earnings. The coming quarters will test the sustainability of clinical bookings and the integration of recent acquisitions as biotech funding stabilizes.